NRSN short interest
NeuroSense Therapeutics Ltd. · Healthcare · Biotechnology · settlement date 2026-09-30
| Shares short | 26,883 |
|---|---|
| Change vs prior report | -11,353 (-29.7%) |
| Change over six months | -95.5% |
| Days to cover | 1.22 (sector: 3.78) |
| Average daily volume | 22,043 |
| Rank in Healthcare | not ranked (OTC, fund or thinly traded) |
NRSN short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 26,883 | -29.7% | 1.22 | 22,043 |
| 2026-09-15 | 38,236 | -91.8% | 1.00 | 40,192 |
| 2026-08-31 | 469,120 | -4.1% | 1.46 | 322,001 |
| 2026-08-14 | 489,130 | -10.8% | 2.31 | 212,026 |
| 2026-07-31 | 548,046 | +0.1% | 1.22 | 448,304 |
| 2026-07-15 | 547,543 | -6.4% | 6.96 | 78,661 |
| 2026-06-30 | 585,034 | +19.0% | 2.03 | 287,898 |
| 2026-06-15 | 491,665 | +33.0% | 3.29 | 149,482 |
| 2026-05-29 | 369,629 | -24.1% | 3.06 | 120,608 |
| 2026-05-15 | 487,264 | -14.6% | 3.60 | 135,258 |
| 2026-04-30 | 570,759 | -12.7% | 3.75 | 152,111 |
| 2026-04-15 | 653,788 | +10.0% | 5.94 | 110,126 |
| 2026-03-31 | 594,593 | +21.3% | 2.45 | 242,568 |
| 2026-03-13 | 490,109 | -2.7% | 5.03 | 97,460 |
| 2026-02-27 | 503,652 | +28.5% | 2.76 | 182,266 |
| 2026-02-13 | 392,037 | -30.0% | 2.57 | 152,582 |
| 2026-01-30 | 559,856 | -2.5% | 1.89 | 296,860 |
| 2026-01-15 | 574,179 | +3.4% | 2.34 | 245,512 |
| 2025-12-31 | 555,312 | -18.5% | 1.89 | 293,318 |
| 2025-12-15 | 681,153 | +17.2% | 1.74 | 391,796 |
| 2025-11-28 | 581,075 | +139.6% | 1.00 | 641,824 |
| 2025-11-14 | 242,567 | -10.1% | 1.46 | 166,415 |
| 2025-10-31 | 269,729 | -40.7% | 1.21 | 223,113 |
| 2025-10-15 | 454,670 | -15.1% | 1.79 | 253,428 |
| 2025-09-30 | 535,583 | -35.1% | 2.86 | 186,973 |
import finzdata as yf
yf.Ticker("NRSN").short_interest # every report since 2017
yf.Client().short_interest(["NRSN"], start="2018-01-01")Healthcare short interest · NRSN price history · Who owns NRSN · All short interest